Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective
Industry News
- Sep 8, 2021
- 1 min
Yeast probiotic designed to treat diarrhea and strengthen healthy digestive and immune systems
- Jul 30, 2021
- 1 min
Yiviva Advances its Botanical Cancer Drug into the Clinical Development
- Mar 1, 2021
- 2 min
Tetra Bio-Pharma To Monetize Its Dronabinol And Botanical Product Portfolios
- Dec 22, 2020
- 1 min
Brilacidin Received FDA IND Approval for Phase 2 Trial for Covid-19
- Nov 30, 2020
- 2 min
Mytesi is in development for follow-on indications including Covid-19 induced diarrhea
- Nov 10, 2020
- 2 min
GW Pharma Develops a Botanical Drug to Treat Multiple Sclerosis
- Nov 4, 2020
- 2 min
Developing Medicine from Ancient Herbal Medicine to Treat Cancer
- Sep 3, 2020
- 8 min
Botanical drug clinical trial: common issues and future options
- Sep 1, 2020
- 1 min
COVID-19 IND Moves to Phase 2
- Jul 10, 2020
- 2 min
PA opens a 65,000-square-foot Medical Marijuana Production Facility
- Jul 1, 2020
- 2 min
FDA Approves First Drug Derived from Marijuana to Treat Epilepsy
- Jun 26, 2020
- 5 min
Yale Medicine: Herbal Medicine Unlocks New Possibilities for Cancer Treatment
- Jun 26, 2020
- 1 min
New 'non-invasive' cancer treatment 'targets and destroys' 80% of tumor cells
- Jun 17, 2020
- 3 min
FDA Awards $914,600 Contract to Morgan State University Dr. Peng
- Jun 17, 2020
- 6 min
Tetra Bio-Pharma: building business on healing cannabinoid medicines